Gayatri BioOrganics has announced its 35th AGM scheduled for September 23, 2026, where it will seek shareholder approval to rebrand as Ananth BioOrganics. The company is currently reporting zero revenue from operations and widened net losses of Rs. 111.18 lakhs for FY 2025-26. Additionally, the company faces substantial disputed statutory dues exceeding Rs. 24 crore across various legal forums. Investors should note the leadership transition with Mr. Sreedhara Reddy Kanaparthi stepping in as Chairman and Managing Director.
Gayatri BioOrganics Set for Rebrand and Leadership Overhaul
- Net Loss: Rs. 111.18 lakhs (FY26) vs. Rs. 72.65 lakhs (FY25)
- Revenue: Rs. Nil for consecutive fiscal years
Reader Takeaway: Rebranding and leadership changes occur amid nil revenue and significant legal liabilities; monitoring litigation is crucial.
What just happened
Gayatri BioOrganics has issued a formal notice for its 35th Annual General Meeting, scheduled for September 23, 2026. The company is seeking shareholder approval to change its corporate name to 'Ananth BioOrganics Limited'. Alongside the rebrand, shareholders will vote on the appointment of Mr. Sreedhara Reddy Kanaparthi as Chairman and Managing Director, following the resignation of Mr. T.V. Sandeep Kumar Reddy.
Why this matters
The proposed name change and leadership transition signify a potential strategic shift or restructuring effort. However, the company remains in a state of operational inactivity with no revenue reported for the 2025-26 fiscal year. The widening losses and substantial negative equity underscore the financial challenges currently facing the business.
Risks to watch
A primary concern for investors remains the high volume of disputed statutory dues. As of March 31, 2026, the company is engaged in legal disputes involving over Rs. 24 crore in total liabilities, including Central Excise, Income Tax, and Customs duties. While management has obtained legal opinions, these liabilities represent a significant overhang on the company’s financial health.
Context metrics
The company reported total assets of Rs. 171.75 lakhs as of March 31, 2026, against 'Other Equity' of Rs. (11,579.31) lakhs, reflecting the deep fiscal strain on the balance sheet.
What to track next
Shareholders should monitor the outcomes of the 35th AGM and the subsequent legal proceedings regarding the various pending statutory dues. The ability of the new leadership team to address these liabilities and establish a viable revenue-generating business model will be key to any potential turnaround.